Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea

Biomedicine and Pharmacotherapy

Volumn 59, Issue 1-2, 2005, Pages 20-24

  Alibay, Yasmin ^a   Beauchet, Alain ^a   El Mahmoud, Rami ^a   Schmitt, Caroline ^a   Brun Ney, Dominique ^a   Benoit, Marie Odile ^b   Dubourg, Olivier ^a   Boileau, Catherine ^a,c   Jondeau, Guillaume ^a,c   Puy, Hervé ^a,c  

^a HÔPITAL AMBROISE PARÉ   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c Université Paris Ile de France Ouest   (France)

Author keywords

Brain natriuretic peptide; Heart failure; N terminal pro brain natriuretic peptide

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; CREATININE; NATRIURETIC FACTOR; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUTOMATION; BODY MASS; CHEMOLUMINESCENCE; CORRELATION ANALYSIS; CREATININE CLEARANCE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DYSPNEA; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SEX DIFFERENCE;

EID: 20044381654     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2004.06.002     Document Type: Article

References (27)

1. L. Cabanes, B. Richaud-Thiriez, Y. Fulla, F. Heloire, C. Vuillemard, and S. Weber Brain natriuretic peptide blood levels in the differential diagnosis of dyspnea Chest 120 2001 2047 2050
2. H.H. Chen, and J.C. Burnett The natriuretic peptides in heart failure: diagnostic and therapeutic potentials Proc. Assoc. Am. Physicians 111 1999 406 416
3. A. Clerico, S. Del Ry, and D. Giannessi Measurement of cardiac natriuretic hormones (atrial natriuretic peptide, brain natriuretic peptide, and related peptides) in clinical practice: the need for a new generation of immunoassay methods Clin. Chem. 46 2000 1529 1534
4. A. Clerico, G. Iervasi, and G. Mariani Pathophysiologic relevance of measuring the plasma levels of cardiac natriuretic peptide hormones in humans Horm. Metab. Res. 31 1999 487 498
5. D. Cockroft, and M. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
6. Q. Dao, P. Krishnaswamy, R. Kazanegra, A. Harrison, R. Amirnovin, and L. Lenert Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting J. Am. Coll. Cardiol. 37 2001 379 385
7. M. Davis, E. Espiner, G. Richards, J. Billings, I. Town, and A. Neill Plasma brain natriuretic peptide in assessment of acute dyspnea Lancet 343 1994 440 444
8. J. Duncan, I. Kenneth, M.S. Schlight, and J.R. Booth Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction J. Cardiac. Failure 6 2000 2 8
9. A. Hammerer-Lercher, E. Neubauer, S. Muller, O. Pachinger, B. Puschendorf, and J. Mair Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction Clin. Chim. Acta 310 2001 193 197
10. P.J. Hunt, A.M. Richards, M.G. Nicholls, T.G. Yandle, R.N. Doughty, and E.A. Espiner The amino-terminal portion of pro-brain natriuretic peptide (NT-proBNP): a new marker of cardiac impairment Clin. Endocrinol. (Oxf.) 47 1997 287 296
11. P.J. Hunt, T.G. Yandle, M.G. Nicholls, A.M. Richards, and E.A. Espiner The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma Biochem. Biophys. Res. Commun. 214 1995 1175 1183
12. Y. Ishizaka, Y. Yamamoto, T. Fukunaga, N. Yokota, O. Kida, and K. Kitamura Plasma concentration of human brain natriuretic peptide in patients on hemodialysis Am. J. Kidney Dis. 24 1994 461 472
13. A. Luchner, J.C. Burnett, M. Jougasaki, H.W. Hense, I.M. Heid, and F. Muders Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population J. Hypertens. 18 2000 1121 1128
14. A. Luchner, C. Hengstenberg, H. Lowel, J. Trawinski, M. Baumann, and G.A. Riegger N-terminal pro-brain natriuretic peptide after myocardial infarction: a marker of cardio-renal function Hypertension 39 2002 99 104
15. T.A. Mc Donagh, S.D. Robb, D.R. Murdoch, J. Mc Cord, J.E. Hollander, and P. Duc Biochemical detection of left-ventricular systolic dysfunction Lancet 351 1998 9 13
16. J. Mair, A. Hammerer-Lercher, and B. Puschendorf The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure Clin. Chem. Lab. Med. 39 2001 571 588
17. A.S. Maisel, P. Krishnaswamy, R.M. Nowak, J. Mc Cord, J.E. Hollander, and P. Duc Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N. Engl. J. Med. 347 2002 161 167
18. F. Mallamaci, C. Zoccali, G. Tripepi, M. Salio, N. De Angelis, and E. Nicolis Diagnostic potential of cardiac natriuretic peptides in dialysis patients Kidney Int. 59 2001 1559 1566
19. S. Masson, T. Vago, G. Baldi, M. Salio, N. De Angelis, and E. Nicolis Comparative measurement of N-terminal pro-BNP and BNP in ambulatory patients with heart failure Clin. Chem. Lab. Med. 40 2002 761 763
20. L.K. Morrison, A. Harrison, P. Krishnaswamy, R. Kazanegra, P. Clopton, and A.S. Maisel Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea J. Am. Coll. Cardiol. 39 2002 202 209
21. M.M. Redfield, R.J. Rodeheffer, S.J. Jacobsen, D.W. Mahoney, K.R. Bailey, and J.C. Burnett Plasma brain natriuretic peptide concentration: impact of age and gender J. Am. Coll. Cardiol. 40 2002 976 982
22. A.M. Richards, M.G. Nicholls, T.G. Yandle, C. Frampton, E.A. Espiner, and J.G. Turner Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction Circulation 97 1998 1921 1929
23. H. Sayama, Y. Nakamura, N. Saito, and M. Kinoshita Why is the concentration of plasma brain natriuretic peptide in elderly inpatients greater than normal? Coron. Artery Dis. 10 1999 537 540
24. H. Smith, R.M. Pickering, A. Stuthers, I. Simpson, and D. Mant Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study Br. Med. J. 320 2000 906 908
25. B. Stanek, B. Frey, M. Hulsamnn, R. Berger, B. Sturm, and Strametz-Juranek Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction J. Am. Coll. Cardiol. 38 2001 436 442
26. S. Talwar, I.B. Squire, J.E. Davies, D.B. Barnett, and L.L. Ng Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population Eur. Heart J. 20 1999 1736 1744
27. The task force on heart failure of the European society of cardiology. Guidelines for the diagnosis of heart failure Eur. Heart J. 16 1995 741 751